Attention deficit and hyperactivity disorder (ADHD) is not restricted to children. Abundant evidence from follow-up studies accumulated since the 1970s supports the concept of ADHD in adulthood. Genetic research points to a heritability of 76%, and neuroimaging studies have reported structural and functional brain abnormalities in patients with ADHD. Contrary to popular belief, ADHD is not a culturally bound disorder and has been described worldwide. ADHD has a cost for society, as adults with this disorder suffer from increased rates of unemployment and psychiatric comorbidity, including substance use disorders. Studies undertaken in forensic populations describe high rates of ADHD in these groups, particularly amongst young offenders. One of the main issues in the diagnosis of ADHD in the adult is the fact that most clinicians have not been educated to diagnose and treat ADHD. Effective pharmacological treatments for ADHD are available and should be prescribed for these patients. The National Institute for Health and Clinical Excellence (NICE) and the British Association for Psychopharmacology (BAP) guidelines established a benchmark for service development required to treat ADHD adequately in the adult population. However, the implementation of new services has been slow. More resources are needed to effectively assess and treat ADHD in the adult.
AdlerLASpencerTJLevineLR. (2008) Functional outcomes in the treatment of adults with ADHD. J Atten Disord11: 720–727.
2.
Arcos-BurgosMJainMAcostaMT. (2010) Common variant of the latrophilin 3 gene, LPHN3, confers susceptibility to ADHD and predicts effectiveness of stimulant medication. Mol Psychiatry15: 1053–1066.
3.
AriasAJGelernterJChanGWeissRDBradyKTFarrerLKranzlerHR (2008) Correlates of co-occurring ADHD in drug-dependent subjects: prevalence and features of substance dependence and psychiatric disorders. Addict Behav. 33: 1199–207.
4.
AshersonP (2005) Clinical assessment and treatment of attention deficit hyperactivity disorder in adults. Expert Review of Neurotherapeutics5: 525–539.
5.
BiedermanJFaraoneSVKeenanK. (1992) Further evidence for family-genetic risk factors in attention deficit hyperactivity disorder. Patterns of comorbidity in probands and relatives psychiatrically and pediatrically referred samples. Arch Gen Psychiatry49: 728–738.
6.
BiedermanJFaraoneSVKneeD. (1990) Retrospective assessment of DSM-III attention deficit disorder in non referred individuals. J Clin Psychiatry51: 102–106.
7.
BiedermanJNewcornJSprichS (1991) Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders. Am J Psychiatry148: 564–577.
8.
BradleyC (1950) Benzedrine and Dexedrine in the treatment of children’s behaviour disorders. Pediatrics5: 24–37.
9.
CarpentierPJvan GoghMTKnapenLJ. (2010) Influence of attention deficit hyperactivity disorder and conduct disorder on opioid dependence severity and psychiatric comorbidity in chronic methadone-maintained patients. Eur Addict Res 201117(1): 10–20.
10.
CrichtonA (2008) An enquiry into the nature and origin of mental derangement: On attention and its diseases. J Atten Disord12: 200.
11.
De GraafRKesslerRCFayyadJ. (2008) The prevalence and effects of adult attention-deficit/hyperactivity disorder (ADHD) on the performance of workers: results from the WHO World Mental Health Survey Initiative. Occup Environ Med65: 835–842.
12.
EdvinssonDBingeforsKLindströmE. (2010) ADHD-related symptoms among adults in out-patient psychiatry and female prison inmates as compared with the general population. Ups J Med Sci115: 30–40.
13.
FayyadJDe GraafRKesslerR. (2007) Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br J Psychiatry190: 402–409.
14.
FaraoneSVBiedermanJSpencerT. (2000) Attention-deficit/hyperactivity disorder in adults: An overview. Biol Psychiatry48: 9–20.
15.
FaraoneSVBuitelaarJ (2010) Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis. Eur Child Adolesc Psychiatry19: 353–364.
16.
FaraoneSVGlattSJ (2010) A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes. J Clin Psychiatry71: 754–763.
17.
FaraoneSVPerlisRHDoyleAE. (2005) Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry57: 1313–1323.
18.
FaraoneSVSergeantJGillbergC. (2003) The worldwide prevalence of ADHD. Is it an American condition?World Psychiatry2: 2.
19.
FassbenderCSchweitzerJB (2006) Is there evidence for neural compensation in attention deficit hyperactivity disorder? A review of the functional neuroimaging literature. Clin Psychol Rev26: 445–465.
20.
GittelmanRMannuzzaSShenkerR. (1985) Hyperactive boys almost grown up. I. Psychiatric status. Arch Gen Psychiatry42: 937–947.
21.
GoksøyrPKNøttestadJA (2008) The burden of untreated ADHD among adults: the role of stimulant medication. Addict Behav33: 342–346.
22.
GoldsteinS (2006) Is ADHD a growth industry?J Atten Disord9: 461–464.
23.
GreenfieldBHechtmanLWeissG (1988) Two subgroups of hyperactives as adults: correlations of outcome. Can J Psychiatry33: 505–508.
24.
HesseSBallaschkeOBarthelH. (2009) Dopamine transporter imaging in adult patients with attention-deficit/hyperactivity disorder. Psychiatry research. Neuroimaging171: 120–128.
25.
KooijSJBejerotSBlackwellA. (2010) European consensus statement on diagnosis and treatment of adult ADHD The European Network Adult ADHD. BMC Psychiatry10: 67.
26.
KrauseKHDreselSHKrauseJ. (2000) Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: effects of methylphenidate as measured by single photon emission computed tomography. Neurosci Lett285: 107–110.
27.
KrauseJLa FougereCKrauseKH. (2005) Influence of striatal dopamine transporter availability on the response to methylphenidate in adult patients with ADHD. Eur Arch Psychiatry Clin Neurosci255: 428–431.
28.
NICE (National Institute for Health and Clinical Excellence) (2008) Attention deficit hyperactivity disorder: the diagnosis and management of ADHD in children, young people and adults. Available at: www.nice.org.uk/nicemedia/pdf/CG72NiceGuidelinev3.pdf (accessed 11 May 2011).
29.
NuttDJFoneKAshersonP. (2007) Evidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for Psychopharmacology. J Psychopharmacol21: 10–41.
30.
MannuzzaSKleinRGBonaguraN. (1991) Hyperactive boys almost grown up. V. Replication of psychiatric status. Arch Gen Psychiatry48: 77–83.
31.
MészárosACzoborPBálintS. (2009) Pharmacotherapy of adult attention deficit hyperactivity disorder (ADHD): a meta-analysis. Int Neuropsychopharmacol12: 1137–1147.
32.
O’GormanRMehtaMAAshersonP. (2008) Increased cerebral perfusion in adult attention deficit hyperactivity disorder is normalized by stimulant treatment: A non-invasive MRI pilot study. Neuroimaging42: 36–41.
33.
PolanczykGDe LimaMSHortaBL. (2007) The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry164: 942–948.
34.
RibasésMRamos-QuirogaJASánchez-MoraC. (2011) Contribution of LPHN3 to the genetic susceptibility to ADHD in adulthood: a replication study. Genes, Brain, and Behavior10: 149–157.
35.
RöslerMRetzWRetz-JungingerP. (2004) Prevalence of attention deficit-/hyperactivity disorder (ADHD) and comorbid disorders in young male prison inmates. Eur Arch Psychiatry Clin Neurosci254: 365–367.
36.
SchneiderMFKrickCMRetzW. (2010) Impairment of fronto-striatal and parietal cerebral networks correlates with attention deficit hyperactivity disorder (ADHD) psychopathology in adults – a functional magnetic resonance imaging (fMRI) study. Psychiatry Res183: 75–84.
37.
SchneiderMRetzWCooganA. (2006) Anatomical and functional brain imaging in adult attention-deficit/hyperactivity disorder (ADHD) – a neurological view. Eur Arch Psychiatry Clin Neurosci256(Suppl 1): i32–i41.
38.
ShawPRabinC (2009) New insights into attention-deficit/hyperactivity disorder using structural neuroimaging. Curr Psychiatry Rep11: 393–398.
39.
SimonVCzoborPBálintS. (2009) valence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis. Br J Psychiatry194: 204–211.
40.
SinghI (2008) Beyond polemics: science and ethics of ADHD. Nat Rev Neurosci9: 957–964.
41.
SpencerTJLandgrafJMAdlerLA. (2008) Attention-deficit/hyperactivity disorder-specific quality of life with triple-bead mixed amphetamine salts (SPD465) in adults: results of a randomized, double-blind, placebo-controlled study. J Clin Psychiatry69: 1766–1775.
42.
StillGF (2006) Some abnormal psychical conditions in children: Excerpts from three lectures. J Atten Disord10: 126.
43.
WenderPHReimherrFWWoodDR (1981) Attention deficit disorder (‘minimal brain dysfunction’) in adults. A replication study of diagnosis and drug treatment. Arch Gen Psychiatry38: 449–456.
44.
WoodDRReimherrFWWenderPH. (1976) Diagnosis and treatment of minimal brain dysfunction in adults: a preliminary report. Arch Gen Psychiatry33: 1453–1460.
45.
YanWW (1998) An investigation of adult outcome of hyperactive children in Shanghai. Psychiatry Clin Neurosci52 (Suppl): S303–S305.
46.
YoungSAdamouMBoleaB. (2011) The identification and management of ADHD offenders within the criminal justice system: a consensus statement from the UK Adult ADHD Network and criminal justice agencies. BMC Psychiatry11: 32.
47.
YoungSAmarasingheJM (2010) Practitioner review: Non-pharmacological treatments for ADHD: a lifespan approach. J Child Psychol Psychiatry51: 116–1133.
48.
YoungSGudjonssonGHMischP. (2010) Prevalence of ADHD symptoms among youth in a secure facility: The consistency and accuracy of self- and informant-report ratings. J Forensic Psychiatry Psychol21: 238–246.
49.
YoungSGudjonssonGWellsJ. (2009) Attention Deficit Hyperactivity Disorder and critical incidents in a Scottish prison population. Pers Individ Diff46: 265–269.
